Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic Sclerosis

NCT06915181 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Logistically the study had to be stopped.

Conditions

Systemic Sclerosis With Dysphagia

Interventions

DRUG: Pyridostigmine

Sponsor

Universitair Ziekenhuis Brussel